{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T05:00:32Z","timestamp":1784091632885,"version":"3.55.0"},"reference-count":28,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T00:00:00Z","timestamp":1750118400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec><jats:title>Objectives<\/jats:title><jats:p>Lymphangioleiomyoma (LAM) is a rare multisystemic disease with variable clinical manifestations. This study aim to evaluate the potential of neutrophils and neutrophil-to-lymphocyte ratio (NLR) in predicting treatment response and prognosis in LAM.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Lymphangioleiomyoma patients hospitalized in the respiratory department from January 2013 to January 2024 were retrospectively collected. Baseline data, routine blood tests, pulmonary function, and lung computed tomography (CT) were recorded, and the NLR was calculated. Patients were divided into pneumothorax and no-pneumothorax groups based on pneumothorax occurrence. Differences between the two groups were compared, and significantly different indicators were further analyzed.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>A total of 78 patients with LAM were included in the study, 42 of them developed pneumothorax from registration to the end of follow-up, and 36 did not develop pneumothorax. There were differences in neutrophils, eosinophils, and NLR between the two groups (<jats:italic>P<\/jats:italic> &amp;lt; 0.05). Further analysis revealed that neutrophils and NLR were negatively correlated with lung function in LAM patients (<jats:italic>P<\/jats:italic> &amp;lt; 0.05), and positively correlated with lung CT grading and pneumothorax occurrence. Sirolimus treatment reduced neutrophil and NLR values in the pneumothorax group of LAM patients in (<jats:italic>P<\/jats:italic> &amp;lt; 0.05).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Lymphangioleiomyoma patients with higher neutrophil and NLR values have worse lung function and may be more susceptible to spontaneous pneumothorax, and sirolimus treatment reduces neutrophil and NLR values in LAM patients with pneumothorax.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fmed.2025.1523885","type":"journal-article","created":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T05:28:02Z","timestamp":1750138082000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Neutrophil and neutrophil-lymphocyte ratios as predictors of clinical characteristics in patients with Lymphangioleiomyomatosis"],"prefix":"10.3389","volume":"12","author":[{"given":"Lulu","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liting","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingquan","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siying","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,6,17]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1016\/S2213-2600(21)00228-9","article-title":"Lymphangioleiomyomatosis: Pathogenesis, clinical features, diagnosis, and management.","volume":"9","author":"McCarthy","year":"2021","journal-title":"Lancet Respir Med."},{"key":"B2","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/j.chest.2018.06.016","article-title":"The NHLBI LAM registry: Prognostic physiologic and radiologic biomarkers emerge from a 15-year prospective longitudinal analysis.","volume":"155","author":"Gupta","year":"2019","journal-title":"Chest."},{"key":"B3","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1055\/s-0040-1702195","article-title":"Lymphangioleiomyomatosis.","volume":"41","author":"Xu","year":"2020","journal-title":"Semin Respir Crit Care Med."},{"key":"B4","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1089\/lrb.2009.0024","article-title":"The natural history of lymphangioleiomyomatosis: Markers of severity, rate of progression and prognosis.","volume":"8","author":"Taveira\u2013DaSilva","year":"2010","journal-title":"Lymphatic Res Biol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/S2213-2600(13)70090-0","article-title":"Serum VEGF-D concentration as a biomarker of lymphangioleiomyomatosis severity and treatment response: A prospective analysis of the Multicenter International Lymphangioleiomyomatosis Efficacy of Sirolimus (MILES) trial.","volume":"1","author":"Young","year":"2013","journal-title":"Lancet Respir Med."},{"key":"B6","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.chest.2017.05.012","article-title":"Long-Term effect of sirolimus on serum vascular endothelial growth factor D levels in patients with lymphangioleiomyomatosis.","volume":"153","author":"Taveira-DaSilva","year":"2018","journal-title":"Chest."},{"key":"B7","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1378\/chest.10-0573","article-title":"Serum vascular endothelial growth factor-D prospectively distinguishes lymphangioleiomyomatosis from other diseases.","volume":"138","author":"Young","year":"2010","journal-title":"Chest."},{"key":"B8","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1146\/annurev-pathol-020712-164023","article-title":"The multifaceted functions of neutrophils.","volume":"9","author":"Mayadas","year":"2014","journal-title":"Annu Rev Pathol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1530\/ERC-19-0431","article-title":"Neutrophil elastase from myeloid cells promotes TSC2-null tumor growth.","volume":"27","author":"Taya","year":"2020","journal-title":"Endocr Relat Cancer."},{"key":"B10","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1002\/acr.24880","article-title":"Blood neutrophil count and neutrophil-to-lymphocyte ratio for prediction of disease progression and mortality in two independent systemic sclerosis cohorts.","volume":"75","author":"Wareing","year":"2023","journal-title":"Arthritis Care Res."},{"key":"B11","doi-asserted-by":"publisher","first-page":"e001202","DOI":"10.1136\/bmjresp-2022-001202","article-title":"Neutrophil lymphocyte ratio as an indicator for disease progression in Idiopathic Pulmonary Fibrosis.","volume":"9","author":"Achaiah","year":"2022","journal-title":"BMJ Open Respir Res."},{"key":"B12","doi-asserted-by":"publisher","first-page":"11719","DOI":"10.26355\/eurrev_202011_23819","article-title":"The neutrophil to lymphocyte ratio as a novel predictor of asthma and its exacerbation: A systematic review and meta-analysis.","volume":"24","author":"Huang","year":"2020","journal-title":"Eur Rev Med Pharmacol Sci."},{"key":"B13","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1164\/rccm.201607-1384ST","article-title":"Official American Thoracic Society\/Japanese respiratory society clinical practice guidelines: Lymphangioleiomyomatosis diagnosis and management.","volume":"194","author":"McCormack","year":"2016","journal-title":"Am J Respir Crit Care Med."},{"key":"B14","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1148\/radiol.2421051767","article-title":"Sporadic Lymphangioleiomyomatosis and tuberous sclerosis complex with lymphangioleiomyomatosis: Comparison of CT features.","volume":"242","author":"Avila","year":"2007","journal-title":"Radiology."},{"key":"B15","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1186\/s13023-022-02418-2","article-title":"Sirolimus reduces the risk of pneumothorax recurrence in patients with lymphangioleiomyomatosis: A historical prospective self-controlled study.","volume":"17","author":"Cheng","year":"2022","journal-title":"Orphanet J Rare Dis."},{"key":"B16","doi-asserted-by":"publisher","first-page":"e230102","DOI":"10.1530\/ERC-23-0102","article-title":"Lymphangioleiomyomatosis: Where endocrinology, immunology and tumor biology meet.","volume":"30","author":"Gibbons","year":"2023","journal-title":"Endocr Relat Cancer."},{"key":"B17","doi-asserted-by":"publisher","first-page":"bqad061","DOI":"10.1210\/endocr\/bqad061","article-title":"Estradiol augments tumor-induced neutrophil production to promote tumor cell actions in lymphangioleiomyomatosis models.","volume":"164","author":"Minor","year":"2023","journal-title":"Endocrinology."},{"key":"B18","doi-asserted-by":"publisher","first-page":"104173","DOI":"10.1016\/j.lpm.2023.104173","article-title":"Lymphangioleiomyomatosis.","volume":"52","author":"Elia","year":"2023","journal-title":"Presse Med."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1016\/j.chest.2022.05.036","article-title":"Impact of age, menopause, and sirolimus on spontaneous pneumothoraces in lymphangioleiomyomatosis.","volume":"162","author":"Cortinas","year":"2022","journal-title":"Chest."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1378\/chest.129.5.1274","article-title":"Management of pneumothorax in lymphangioleiomyomatosis.","volume":"129","author":"Almoosa","year":"2006","journal-title":"Chest."},{"key":"B21","doi-asserted-by":"publisher","first-page":"2621","DOI":"10.1056\/NEJMc053410","article-title":"Doxycycline treatment for lymphangioleiomyomatosis with urinary monitoring for MMPs.","volume":"354","author":"Moses","year":"2006","journal-title":"N Engl J Med."},{"key":"B22","doi-asserted-by":"publisher","first-page":"267","DOI":"10.5858\/2000-124-0267-RFAOMM","article-title":"Role for activation of matrix metalloproteinases in the pathogenesis of pulmonary lymphangioleiomyomatosis.","volume":"124","author":"Matsui","year":"2000","journal-title":"Arch Pathol Lab Med."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1016\/s0046-8177(06)80039-0","article-title":"Role of elastic fiber degradation in emphysema-like lesions of pulmonary lymphangiomyomatosis.","volume":"21","author":"Fukuda","year":"1990","journal-title":"Hum Pathol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"605909","DOI":"10.3389\/fmed.2021.605909","article-title":"Exploring the role of matrix metalloproteinases as biomarkers in sporadic lymphangioleiomyomatosis and tuberous sclerosis complex. A pilot study.","volume":"8","author":"Terraneo","year":"2021","journal-title":"Front Med."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1079317","DOI":"10.3389\/fmed.2023.1079317","article-title":"Lymphangioleiomyomatosis: Searching for potential biomarkers.","volume":"10","author":"Revilla-L\u00f3pez","year":"2023","journal-title":"Front Med."},{"key":"B26","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1097\/SHK.0000000000000386","article-title":"Kinetics and role of plasma matrix metalloproteinase-9 expression in acute lung injury and the acute respiratory distress syndrome.","volume":"44","author":"Hsu","year":"2015","journal-title":"Shock."},{"key":"B27","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1111\/all.12414","article-title":"Neutrophils from allergic asthmatic patients produce and release metalloproteinase-9 upon direct exposure to allergens.","volume":"69","author":"Ventura","year":"2014","journal-title":"Allergy."},{"key":"B28","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.yexcr.2014.11.004","article-title":"Aldosterone up-regulates MMP-9 and MMP-9\/NGAL expression in human neutrophils through p38, ERK1\/2 and PI3K pathways.","volume":"331","author":"Gilet","year":"2015","journal-title":"Exp Cell Res."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2025.1523885\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T05:28:03Z","timestamp":1750138083000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2025.1523885\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,17]]},"references-count":28,"alternative-id":["10.3389\/fmed.2025.1523885"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2025.1523885","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,17]]},"article-number":"1523885"}}